2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
7
Head & Neck
4
NET
3
Tumor-Agnostic
2
Other solid neoplasm
2
Thoracic
1
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Interventions
Paclitaxel
581
Carboplatin
527
Cisplatin
355
Bevacizumab
256
pembrolizumab
226
Gemcitabine
157
liposomal doxorubicin
132
Topotecan
131
olaparib
129
Cyclophosphamide
126
Radiotherapy
118
Taxes
114
Docetaxel
95
Brachytherapy
94
Drug Therapy
90
niraparib
88
Doxorubicin
86
Surveys and Questionnaires
85
Magnetic Resonance Spectroscopy
80
Blood Specimen Collection
73
Nivolumab
71
Specimen Handling
70
Hyperthermic Intraperitoneal Chemotherapy
64
Biopsy
63
fludarabine
56
Filgrastim
53
Letrozole
50
Oxaliplatin
49
durvalumab
47
Immunoglobulin G
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
fosbretabulin
×
Gynecologic
×
Clear all
NCT02055690
2021-05-17
PAZOFOS
The Christie NHS Foundation Trust
Phase 1/2
Terminated
21 enrolled